SCHEMBL8552244

SCHEMBL8552244

CC(CC(=O)O)Cc1nc(-c2ccccc2)c(-c2ccc(S(N)(=O)=O)cc2)o1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 14/20 0.58
RXRA P19793 8/20 0.58
NR4A1 P22736 2/20 0.51
NR4A3 Q92570 2/20 0.51
RXRB P28702 7/20 0.49
RXRG P48443 4/20 0.49
PTGS2 P35354 3/20 0.49
PTGS1 P23219 2/20 0.49
KDM4E B2RXH2 1/20 0.49
ABCC4 O15439 1/20 0.49
C5 P01031 1/20 0.49
LMNA P02545 1/20 0.49
CHRM2 P08172 1/20 0.49
CYP3A4 P08684 1/20 0.49
CHRM1 P11229 1/20 0.49
DRD2 P14416 1/20 0.49
HPGD P15428 1/20 0.49
TSHR P16473 1/20 0.49
TBXA2R P21731 1/20 0.49
HTR2A P28223 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8546106 0.90 NR4A2 (0.54) NR4A2RXRANR4A1NR4A3RXRB
SCHEMBL6000516 0.87 NR4A2 (0.78) NR4A2RXRANR4A1NR4A3RXRB
SCHEMBL6002174 0.87 NR4A2 (0.78) NR4A2RXRANR4A1NR4A3RXRB
SCHEMBL8546885 0.87 NR4A2 (0.59) NR4A2RXRANR4A1NR4A3RXRB
SCHEMBL8552246 0.84 NR4A2 (0.51) NR4A2RXRANR4A1NR4A3RXRB
SCHEMBL5763378 0.83 NR4A2 (0.75) NR4A2RXRANR4A1NR4A3RXRB
SCHEMBL5734304 0.83 NR4A2 (0.75) NR4A2RXRANR4A1NR4A3RXRB
SCHEMBL6002081 0.83 NR4A2 (0.79) NR4A2RXRANR4A1NR4A3RXRB
SCHEMBL6002019 0.83 NR4A2 (0.79) NR4A2RXRANR4A1NR4A3RXRB
SCHEMBL9097443 0.82 NR4A2 (0.55) NR4A2RXRANR4A1NR4A3RXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP claimed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO claimed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO disclosed